arrow
Back
J

Jacqueline Cloos

vrije universiteit amsterdam

58H-index
395Paper Count
1.6WCitation Count
Published Papers 115
Publication Date
CytoScan: Automated Detection of Technical Anomalies for Cytometry Quality Control
err2026-07-06
err0
errOAAI
errTim R. Mocking; Felix Zwolle; Yejin Park; Angèle Kelder; Yvan Saeys; Jacqueline Cloos; Sofie van Gassen; Costa Bachas
errShare
errSave
Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy
err2026-03-19
err0
PREAI
errLukas H. Haaksma; Tom Reuvekamp; Kasper J. Croese; Maximiliaan Muijtjens; Angéle Kelder; Daphne den Hartog; Willemijn J. Scholten; Thomas Pabst; Saskia K. Klein; Georg Stüssi; Laimonas Griskevicius; Dimitri A. Breems; Lidwine Tick; Alexandra Herbers; Susan de Jonge; Dana A. Chitu; Costa Bachas; Gerwin Huls; Jacqueline Cloos; David C. de Leeuw
errShare
errSave
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party
errBlood
IF23.1
err2025-12-16
err0
errOAAI
errJacqueline Cloos; Peter J. M. Valk; Christian Thiede; Konstanze Döhner; Gail J. Roboz; Brent L. Wood; Roland B. Walter; Sa Wang; Agnieszka Wierzbowska; Andrew H. Wei; David Wu; François Vergez; Adriano Venditti; Bert A. van der Reijden; Arjan A. van de Loosdrecht; Ing Soo Tiong; Felicitas R. Thol; Marion Subklewe; Christophe Roumier; Tom Reuvekamp
errShare
errSave
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia
errLeukemia
IF13.4
err2025-12-10
err0
errOAAI
errLukas H. Haaksma; Raffaele Palmieri; Tom Reuvekamp; Jesse M. Tettero; Lok Lam Ngai; Costa Bachas; Angèle Kelder; Willemijn J. Scholten; Patrycja Gradowska; Valentina Arena; Anderson João Simione; Luca Maurillo; Adriano Venditti; Bob Löwenberg; Gert J. Ossenkoppele; David C. de Leeuw; Maura R. V. Ikoma-Colturato; Francesco Buccisano; Jacqueline Cloos
errShare
errSave
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients
err2025-12-01
err2
errOAAI
errNgai, Lok Lam; Reuvekamp, Tom; Hanekamp, Diana; Janssen, Fleur; Oudshoorn-van Marsbergen, Laura; Carbaat-Ham, Jannemieke; Hofland, Maaike A. M.; Fayed, Mona M. H. E.; Kelder, Angele; Scholten, Willemijn J.; Snel, Alexander N.; Bachas, Costa; Tettero, Jesse M.; Breems, Dimitri A.; Fischer, Thomas; Gjertsen, Bjorn T.; Griskevicius, Laimonas; Juliusson, Gunnar; van de Loosdrecht, Arjan A.; Maertens, Johan A.; Manz, Markus G.; Pabst, Thomas; Passweg, Jakob R.; Porkka, Kimmo; Valk, Peter J. M.; Gradowska, Patrycja; Lowenberg, Bob; Ossenkoppele, Gert J.; de Leeuw, David C.; Cloos, Jacqueline
errShare
errSave
Computationally efficient multi-sample flow cytometry data analysis using Gaussian mixture models
err2025-10-25
err0
errOAAI
errPhilip Rutten; Tim R. Mocking; Jacqueline Cloos; Wessel N. van Wieringen; Costa Bachas
errShare
errSave
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial
errLeukemia
IF13.4
err2025-09-03
err0
errOAAI
errTim R. Mocking; Lukas H. Haaksma; Tom Reuvekamp; Angèle Kelder; Willemijn J. Scholten; Lok Lam Ngai; Dimitri A. Breems; Thomas Fischer; Bjørn T. Gjertsen; Laimonas Griškevičius; Gunnar Juliusson; Johan A. Maertens; Markus G. Manz; Thomas Pabst; Jakob R. Passweg; Kimmo Porkka; Peter J. M. Valk; Patrycja Gradowska; Bob Löwenberg; David C. de Leeuw; Jeroen J. W. M. Janssen; Gert J. Ossenkoppele; Arjan A. van de Loosdrecht; Jacqueline Cloos; Costa Bachas
errShare
errSave
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets
err2025-05-29
err0
PREAI
errJaco C. Knol; Mengge Lyu; Franziska Böttger; Madalena Nunes Monteiro; Thang V. Pham; Frank Rolfs; Andrea Vallés-Martí; Tim Schelfhorst; Richard R. de Goeij-de Haas; Irene V. Bijnsdorp; Shuaiyao Wang; Fangfei Zhang; Jun A; Bart A. Westerman; Barbara Sitek; Janne Lehtiö; Jan Koster; Jan N.M. IJzermans; Hanneke W.M. van Laarhoven; Maarten F. Bijlsma; Jan Paul Medema; Alex A. Henneman; Sander R. Piersma; Ruud H. Brakenhoff; Jacqueline Cloos; Valentina Cordo'; Daphne de Jong; Geert Kazemier; Danijela Koppers-Lalic; Mariette Labots; Tessa Y.S. Le Large; John W.M. Martens; Jules P.P. Meijerink; Madiha Mumtaz; Chantal Scheepbouwer; Robby E. Kibbelaar; David P. Noske; Renske D.M. Steenbergen; Nicole C.T. van Grieken; Winan van Houdt; Elisa Giovannetti; Geert J.L.H. van Leenders; Jos Jonkers; Tong Liu; Meisi Yan; Xiaolu Zhan; Tiannan Guo; Connie R. Jimenez
errShare
errSave
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia
err2025-05-21
err0
errOAAI
errMocking, Tim R.; van de Loosdrecht, Arjan A.; Cloos, Jacqueline; Bachas, Costa
errShare
errSave
Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models
err2024-12-19
err1
errOAAI
errMocking, Tim R.; Kelder, Angele; Reuvekamp, Tom; Ngai, Lok Lam; Rutten, Philip; Gradowska, Patrycja; van de Loosdrecht, Arjan A.; Cloos, Jacqueline; Bachas, Costa
errShare
errSave
Acute myeloid leukemia: does sex matter?
errLEUKEMIA
IF13.4
err2024-10-14
err0
errOAAI
errTettero, Jesse M.; Cloos, Jacqueline; Bullinger, Lars
errShare
errSave
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome
err2024-10-05
err0
errOAAI
errHuls, Gerwin; Chitu, Dana A.; Tick, Lidwine; Boersma, Rinske; Breems, Dimitri; Herbers, Alexandra; Klein, Saskia K.; de Jonge, Suzan; Westerweel, Peter E.; Cruijsen, Marjan; Hoogendoorn, Mels; Cuijpers, Marlous; Deeren, Dries; Bailly, Benjamin; Visser, Otto; van Rhenen, Anna; Posthuma, Eduard F. M.; Valk, Peter J. M.; Cloos, Jacqueline; Ammatuna, Emanuele; Refos, Jeannine M.; Fakkert, R.; Lowenberg, Bob; Ossenkoppele, Gert J.
errShare
errSave
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)
errLEUKEMIA
IF13.4
err2024-08-21
err1
PREAI
errRodriguez-Arboli, Eduardo; Othus, Megan; Freeman, Sylvie D.; Buccisano, Francesco; Ngai, Lok Lam; Thomas, Ian; Palmieri, Raffaele; Cloos, Jacqueline; Johnson, Sean; Meddi, Elisa; Russell, Nigel H.; Venditti, Adriano; Gradowska, Patrycja; Ossenkoppele, Gert J.; Lowenberg, Bob; Walter, Roland B.
errShare
errSave
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
err2024-08-08
err0
errOAAI
errBarneh, Farnaz; Koedijk, Joost B.; Wijnen, Noa E.; Meulendijks, Tom; Ashtiani, Minoo; Dunnebach, Ester; Dautzenberg, Noel; Cornel, Annelisa M.; Krippner-Heidenreich, Anja; Klein, Kim; Zwaan, C. Michel; Kuball, Juergen; Nierkens, Stefan; Cloos, Jacqueline; Kaspers, Gertjan J. L.; Heidenreich, Olaf
errShare
errSave
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
err2024-03-27
err2
errOAAI
errvan der Maas, Niek G.; Versluis, Jurjen; Nasserinejad, Kazem; van Rosmalen, Joost; Pabst, Thomas; Maertens, Johan; Breems, Dimitri; Manz, Markus; Cloos, Jacqueline; Ossenkoppele, Gert J.; Floisand, Yngvar; Gradowska, Patrycja; Lowenberg, Bob; Huls, Gerwin; Postmus, Douwe; Pignatti, Francesco; Cornelissen, Jan J.
errShare
errSave
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia
errLEUKEMIA
IF13.4
err2024-01-25
err4
errOAAI
errTettero, Jesse M.; Heidinga, Maaike E.; Mocking, Tim R.; Fransen, Glenn; Kelder, Angele; Scholten, Willemijn J.; Snel, Alexander N.; Ngai, Lok Lam; Bachas, Costa; van de Loosdrecht, Arjan A.; Ossenkoppele, Gert J.; de Leeuw, David C.; Cloos, Jacqueline; Janssen, Jeroen J. W. M.
errShare
errSave
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
err2023-12-01
err0
errOAAI
errTettero, Jesse M.; Buisman, Yara; Ngai, Lok Lam; Bachas, Costa; Gjertsen, Bjorn T.; Kelder, Angele; van de Loosdrecht, Arjan A.; Manz, Markus G.; Pabst, Thomas; Scholten, Willemijn; Ossenkoppele, Gert J.; Cloos, Jacqueline; de Leeuw, David C.
errShare
errSave
Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001
err2023-11-01
err0
errOAAI
errJanssen, Luca L. G.; Westers, Theresia M.; Rovers, Jeroen; Valk, Peter J. M.; Cloos, Jacqueline; de Gruijl, Tanja D.; van de Loosdrecht, Arjan A.
errShare
errSave
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel
err2023-09-06
err7
PREAI
errRavandi, Farhad; Cloos, Jacqueline; Buccisano, Francesco; Dillon, Richard; Doehner, Konstanze; Freeman, Sylvie D.; Hourigan, Christopher S.; Ossenkoppele, Gerrit J.; Roboz, Gail J.; Subklewe, Marion; Thiede, Christian; Arnhardt, Isabell; Valk, Peter J. M.; Venditti, Adriano; Wei, Andrew H.; Walter, Roland B.; Heuser, Michael
errShare
errSave